The Role of Qutenza (Topical Capsaicin 8%) in Treating Neuropathic Pain From Arteriovenous Fistulae in Patients With End Stage Renal Failure
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 08 Nov 2016 Planned End Date changed from 1 Jul 2014 to 1 Aug 2017.
- 08 Nov 2016 Status changed from not yet recruiting to recruiting.
- 14 Jan 2013 New trial record